Development of oral vaccines for preventing diarrhoea caused by enteropathogenic Escherichia coli.
D000268:Adhesiveness; D000818:Animals; D000907:Antibodies, Bacterial / Q000276:immunology; D000918:Antibody Specificity; D000942:Antigens, Bacterial; D000954:Antigens, Surface / Q000276:immunology; D001428:Bacterial Vaccines / Q000276:immunology*; D003967:Diarrhea / Q000662:veterinary*; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000276:immunology* / Q000472:pathogenicity; D004927:Escherichia coli Infections / Q000662:veterinary*; D029968:Escherichia coli Proteins; D005260:Female; D036781:Fimbriae Proteins; D006801:Humans; D007422:Intestines / Q000276:immunology; D010957:Plasmids; D011247:Pregnancy; D013552:Swine; D013553:Swine Diseases / Q000276:immunology*; D014774:Virulence
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001428:Bacterial Vaccines; D029968:Escherichia coli Proteins; C026888:K88 antigen, E coli; D036781:Fimbriae Proteins